
AI drug discovery has progressed from idea/open source to use at the largest pharma companies in the world in 2 years. What felt uncertain at seed seems inevitable today. Huge AI + bio acceleration. @chaidiscovery crushing on the commercial front!
✓Co-founder @Nudge, @Paradigm, @Coinbase

AI drug discovery has progressed from idea/open source to use at the largest pharma companies in the world in 2 years. What felt uncertain at seed seems inevitable today. Huge AI + bio acceleration. @chaidiscovery crushing on the commercial front!

Excited to serve on the President's Technology Council

The human body is a multivariate system that is complex beyond what the human mind can comprehend. Computers will be able to understand and aid the body in ways humans never could. Biology textbook explanations will be looked back on as child-like oversimplifications.

GLP-1s are the first of many trillion-dollar enhancement drugs that will begin as medical treatments


The era of human enhancement

Every human living today will die by default. It’s extremely difficult to solve death. So it’s important to explore many solutions. Cryonics has potential to be a valuable tool. Glad to see @LauraDeming, who is extremely dedicated to this cause, get more resources.


Possible to get 80% of signal in an interview by going extremely deep on an arbitrary topic which (importantly) the interviewee prompts


If you want to work on one of the hardest and the most consequential problem to humankind, reach out! nudge.com/careers/

We've raised a $100M Series A from @ThriveCapital, @greenoaks, and a host of great angels. Everyone’s brain can work better. Engineering that idea into reality is the most impactful advancement we can make to life.

Computers able to zero shot antibody discovery. Science fiction is becoming real.

This is a classic dynamic in internet-based disruptions in other categories. Consolidate, transform, and expand.

The potential rewards are tremendous. Crypto-based services can often operate globally, allowing them to reach scales not otherwise possible and far quicker, consolidating fragmented markets in the process.

Some of these products will be copied from tradfi, some bridged from tradfi, others entirely novel. Some will be off-chain, some on-chain, most hybrid.